Xceleron

Xceleron : A Contract Research Organization Supporting Enhanced Clinical Research in Early Drug Development
Xceleron is an established contract research organization that accelerates early drug development through the ability to apply novel clinical designs and safely evaluate drug effects in humans.
Our world-leading, ultra-sensitive AMS technology has enabled clinical research teams worldwide to significantly reduce development costs and timelines compared to traditional methods.
We provide critical human disposition, bioavailability and metabolism data, including absorption, distribution, metabolism, excretion (ADME) and pharmacokinetic (PK) data for exploratory clinical studies and to support regulatory submission. Our novel approaches can help our clients in clinical research overcome clinical development hurdles and de-risk later stages of drug development.
Xceleron’s expertise and clinical research services have supported over 100 pharmaceutical and biotechnology companies from Phase 0 to Phase III. To date, 7 marketed drugs have used our AMS data for registration. Xceleron has the most experienced team in the application of AMS to clinical programs, with:
• Unmatched global analytical capacity
• Dedicated quality assurance professionals
• Rigorous bioanalytical method development and validation